Opens in a new tab
  • |
    16.10.2026

    Bangladesh Seminar 2026 | Tailin Presents Advanced Solutions for Isolators & Microbiological Quality Control

    Bangladesh Seminar 2026

    On October 14, 2026, Tailin, a leading solutions provider in the life sciences sector, successfully co-hosted a technical seminar in Dhaka, Bangladesh, alongside its local partner, Khan & Deen. Held at the Sheraton Dhaka, the event gathered prominent industry leaders, regulatory experts, and pharmaceutical professionals under the theme “State-of-the-Art Solutions for Isolators & Microbiological Quality Control.”

    The seminar featured opening insights from distinguished figures in the Bangladeshi pharmaceutical industry, including Mr. Muhammad Halimuzzaman, Secretary General of BAPI and CEO of Healthcare Pharmaceuticals Limited; Mr. Mohammad Abul Kalam Azad, Director of Popular Pharmaceuticals PLC; and Mr. Shabbir A. Khan, owner of Khan & Deen. Their opening remarks highlighted the growth trajectory and compliance modernization of the local pharmaceutical market.

    Tailin’s technical experts delivered in-depth presentations focused on practical applications and regulatory compliance. Mr. Marco, Chief Application & Regulatory Expert, presented modern standard demands and operational strategies for both aseptic and containment isolators, as well as pharmacopoeial microbial test and enumeration solutions. Mr. Vincent, Head of South Asia, led technical sharing on isolator glove integrity failure risk analysis, cleanroom verification solutions, and live operational demonstrations.

    The event concluded with an interactive Q&A session addressing validation, qualification, and aseptic processing hurdles. Tailin remains firmly dedicated to supporting pharmaceutical manufacturers worldwide through cutting-edge technology and strict alignment with international standards such as EU-GMP and FDA guidelines, looking forward to fostering stronger partnerships across Bangladesh and beyond.

    Bangladesh Seminar 2026